US Stocks

PureTech Health plc

PureTech Health is a clinical-stage biotherapeutics company that develops and commercializes medicines for various diseases, including inflammatory, neurological, immunological, and gastrointestinal conditions. Some of the therapies developed include KarXT, immunomodulation platform, oral therapies, and hematopoietic stem cell-based therapies. The company has collaboration and license agreements with Boehringer Ingelheim International GMBH, Eli Lilly and Company, Imbrium Therapeutics L.P., and Shionogi & Co., Ltd.